Portfolio

21 Net

The Company was formed in 2001 to develop a system to connect high speed trains to the internet. Using advanced technology, customers on high speed trains travelling at up to 300 kilometres an hour can access information from websites or send and collect urgent emails from their laptop computers and PDAs. The Company secured its first major contract in 2007 to install its system onto 26 trains for Thalys.


Funded by the Advantage Growth Fund
1st Investment: December 2004 | www.21net.com
Sector: ICT


Aeristech Limited

Aeristech has developed a novel fuel efficient and low-cost hybrid turbocharger technology with applications in the automotive and power generation industries. The traditional turbocharger is decoupled into a turbine and a compressor powered by an electric motor. The electrical storage created provides an opportunity to vastly reduce turbo lag resulting in increased performance and reduced emissions. This enables automotive manufacturers to downsize engines without impacting performance.


Funded by the Early Advantage Fund
1st Investment: April 2010 | www.aeristech.co.uk
Sector: Environmental Technologies


Aitua

Aitua provides critical support to new bioventures during the first stages of the technology-to-business translation process. It works closely with entrepreneurs and scientists to create and nurture emerging companies from world-class science and technology deriving from the Babraham Research Campus and other life science clusters in the UK. It provides seed and early stage funding, injects specific expertise and provides access to services and facilities. This reduces cash-burn during the formative years and so enables companies to get off the ground. Aitua has a unique offering designed to accelerate the formation of quality, venture-ready early-stage companies.

Funded by the Rainbow Seed Fund
1st Investment: January 2006 | www.aitua.com
Sector: Medical / Biotechnology


Allinea Software

Based in Warwick Allinea Software span-out of Streamline Computing in July 2009. Allinea Software develops tools that make programming parallel and multithreaded software simple. With cross-platform support and a strong focus on ease-of-use, Allinea products help to scale cluster applications to new heights.

Funded by the Advantage Growth Fund
1st Investment: July 2009 | www.allinea.com
Sector: Software


Anaxsys Technology

Anaxsys Technology, which is based at Keele University in Staffordshire, is a medical technology company developing a suite of devices which allow the diagnosis and monitoring of a variety of respiratory diseases by analysing the humidity profile of human breath. With long term potential to screen for lung cancer and monitoring the treatment of asthma, its first product will be a respiratory rate monitor for use in the care of patients recovering from operations.


Funded by the Early Advantage Fund
1st Investment: February 2010 | www.anaxsys.co.uk
Sector: Medical / Biotechnology


Ardentia

Ardentia is a supplier of world class healthcare business intelligence solutions. Ardentia is the leading dedicated supplier of healthcare solutions in the UK with customers including Trusts, PCTs and Strategic Health Authorities.

Funded by the HSBC Enterprise Fund
1st Investment: February 2000 | www.ardentia.co.uk
Sector: Software


BHMG Marketing

BHMG Marketing was established in August 2005 and provides a full range of marketing services to a wide range of public and private sector organisations, including Advantage West Midlands and a number of local universities.

Funded by the Advantage Growth Fund
1st Investment: August 2005 | www.hmgmarketing.co.uk
Sector: Services


Cellcentric

Epigenetics is the study of the control mechanisms that sit on top of genes and guide the function and fate of individual cells. The field is expected to radically change traditional approaches to many healthcare areas, including cancer therapeutics and tissue regeneration.

Funded by the Rainbow Seed Fund
1st Investment: January 2005 | www.cellcentric.com
Sector: Medical / Biotechnology


Chameleon Biosurfaces

Chameleon Biosurfaces is developing the next generation of polymer coatings for implantable medical devices, such as drug eluting stents.  The polymers provide beneficial features that enhance implants performance.  Beneficial features can include minimising adverse events that can occur in patients after devices have been implanted, and features that help clinicians in the successful deployment of implants during operations.


Funded by the Rainbow Seed Fund
1st Investment: October 2005 | www.chameleonbio.com
Sector: Medical / Biotechnology


Claresys Limited

Claresys Ltd has developed a Compact Optically Scanning Enhanced (COSE) pinhole camera. The COSE Camera Lens has an independent internal zoom and internal pan & tilt capability, using novel optical component arrangements, where the camera remains stationary. With no external moving parts it is possible to scan onto any target subject within the instantaneous field of view of the lens (up to 125O) and then zoom in onto it. Its applications cover surveillance, oil & gas exploration and other hazardous environments.

Funded by the Rainbow Seed Fund
1st Investment: January 2009 | www.claresys.com/Nindex.html
Sector: Medical / Biotechnology


Clearview Systems Limited

Clearview is a leading provider of performance management software for the housing association sector.  The software was originally developed in house by Festival House Group, realising the  commercial potential use of the system to other housing associations the software was span out into a joint venture in 2003.  Clearview has a suite of modules that assist housing associations with strategic business planning, performance management and customer service improvement.  Clearview now has over 90 registered social landlords using the clearview software managing over half a million homes.


Funded by the Advantage Growth Fund
1st Investment: August 2006 | www.clearviewsystems.org
Sector: Software


Colbalt Light Systems

Cobalt Light Systems provides new and proprietary analysis techniques using Raman spectroscopy for high throughput non-invasive pharmaceutical analysis of tablets, capsules, powders etc. incuding chemical and polymorph/amorphous content.  A second technique involves the rapid non-invasive analysis of materials below layers e.g. materials characterisation through coloured and opaque containers for pharmaceuticals/security uses, tissue analysis through skin and academic research.


Funded by the Rainbow Seed Fund
1st Investment: November 2005 | www.cobaltlight.com
Sector: Medical / Biotechnology


Comply Serve

The Company evolved out of the world's leading provider of requirements management solutions, Telelogic AB, where the founding team discovered a significant and largely untapped market opportunity for project supply chain compliance solutions. Comply Serve Limited is a provider of unique, web-based project and product compliance solutions to clients operating in highly regulated industries. Comply Serve's business focus is in markets where there is a need to address complex compliance and assurance goals on high risk, high value programmes of work.

Funded by the Advantage Growth Fund
1st Investment: July 2007 | www.complyserve.com
Sector: Software


Concurrent Thinking

Based in Warwick, Concurrent Thinking span-out of Streamline Computing in March 2010. Streamline has successfully built high performance computing clusters for a large number of UK customers over many years. It has developed pre-configured "Appliances" which enable high performance clusters to be built and configured without the need for highly skilled specialists. Concurrent Thinking will further develop and commercialise these Appliances which can also be used in data-centres, where distributed computing systems are rapidly becoming the norm.

Funded by the Advantage Growth Fund and the Early Advantage Fund
1st Investment: February 2010 | www.concurrent-thinking.com
Sector: ICT


Crescendo Biologics

Crescendo Biologics is developing two proprietary platforms for biological therapeutics from the Babraham Institute: ribosome display for the optimization of antibodies and a transgenic mouse which produces heavy chain only antibodies.


Funded by the Rainbow Seed Fund
1st Investment: June 2008 | www.crescendobiologics.com
Sector: Medical / Biotechnology


Cytox

Cytox is developing a diagnostic test and therapeutic cures for Alzheimer's Disease which is estimated to affect 15 million people worldwide. The company is a university spin-out based on groundbreaking academic research into the role of the cell cycle in neuro-degenerative diseases.


Funded by the Advantage Growth Fund
1st Investment: December 2006 | www.cytoxgroup.com
Sector: Medical / Biotechnology


Dynamic Change

Dynamic Change was formed in March 2000 to develop a web-based performance management software tool. Performance Accelerator is an online integrated corporate governance solution that allows organisations to manage and monitor their business objectives, risks, performance indicators, compliance reporting, financial targets and regulatory obligations. Dynamic Change is the market leader in its chosen market; the NHS. The Company was originally backed by an investment from the HSBC fund in 2002 with a follow-on investment by the Advantage Growth Fund in August 2003.


Funded by the Advantage Growth Fund
1st Investment: August 2003 | www.dynamic-change.co.uk
Sector: Software


Everyclick Ltd

Based in Shipston-on-Stour in Warwickshire, Everyclick is a platform technology company that has created a number of ways for payments to be made to all 200,000 UK charities. It acts as an enabling technology for partners while still providing the ability to users to give to their chosen charities through searching the internet and shopping online through affiliated shopping sites. Everyclick was voted Website of the Year 2008 and was a Tech Media Top 100 2009.

Funded by the Early Advantage Fund
1st Investment: March 2010 | www.everyclick.com
Sector: Other


Gemba Solutions

Gemba Solutions develops real time performance management software. The company has three offerings, Lean Impact, OEE IMPACT Manual Entry and OEE IMPACT Connect. Lean Impact comprises a suite of software modules, each of which is a productivity tool in its own right and when combined, provide the user with a comprehensive manufacturing execution system. Manual Entry and Connect are based on a subset of the full Lean Impact suite, enabling the user to move up to a fully automated system as required.


Funded by the Advantage Growth Fund
1st Investment: November 2006 | www.gembasolutions.co.uk
Sector: Software


Inscentinel

Inscentinel Ltd is a biotechnology company specialising in harnessing the olfactory ability of insects for trace vapour detection. Our primary focus is the development of a new generation of handheld portable detectors, through the use of live honeybees. This unique Inscentinel Technology offers sensitive vapour detection coupled with distinct operational advantages.


Funded by the Rainbow Seed Fund
1st Investment: August 2007 | www.inscentinel.com/
Sector: Environmental Technologies


Ionic Polymer Solutions

IPS is a spin out from Novel Polymer Solutions Limited (NPS), an existing Advantage Growth Fund investment. NPS has granted to IPS the exclusive right to exploit the intellectual property in the manufacture of proton conducting monomers and polymers using novel UV curable diene systems. The technology has a number of potential applications including water free proton conduction in fuel cells and anion pumping for acid regeneration in the metal finishing processes.


Funded by the Advantage Growth Fund
1st Investment: March 2005 | www.ionicpolymersolutions.com
Sector: Environmental Technologies


i-Solutions Global

i-Solutions has developed i-nexus a suite of performance improvement and strategy exaction software. The Company has a US sales office and a truly global blue-chip customer base. Following an initial investment from the Advantage Growth Fund significant further investment has been raised by the company from Herald Venture and Antrak Capital to fund its continued growth development.


Funded by the Advantage Growth Fund
1st Investment: June 2005 | www.i-solutionsglobal.com
Sector: Software


L3 Technology

L3T is addressing the $10bn global market for cholesterol testing, using technology from a leading team of scientists based at STFC's Daresbury Laboratory in Cheshire to develop a diagnostic tool for full spectrum cholesterol testing at the point of care.

A 2004 RSF pathfinder funded some confirmatory research to back up claims in a patent, with further investment since taking the total to £242,000. The company has recently raised a further £1.7m from angels and venture funds and expects to have a fully functioning device within the next six to twelve months.

Funded by the Rainbow Seed Fund
1st Investment: January 2004 | www.l3technology.co.uk
Sector: Medical / Biotechnology


Lontra Limited

Lontra is an innovative clean tech business, which is developing a proprietary energy efficient compressor and engine design with applications including waste water treatment, industrial air and automotive superchargers.


Funded by the Early Advantage Fund
1st Investment: June 2010 | www.lontra.co.uk
Sector: Environmental Technologies


LumeJet Ltd

LumeJet Ltd is a leading light in the world of photonic imaging and is revolutionising the industry. It has developed ground breaking platform technologies - 'LumeJet®Imaging System' and 'LumeJet®Imaging Engine. These bring to the industry lower costs, an easy way to integrate and operate, across a wide and growing range of applications where light is used to activate. The LumePress™is a range of ultra high quality printers that utilises LumeJet's innovative technology - the LumeJet™Imaging Engine. The LumePress™printer range delivers significant cost and quality advantages especially where documents are image intensive or where output quality is key. LumeJet's revolutionary technology can be used in many applications, including third party integration of the core technology for use across a number of industries including - printing, packaging, plastic logic, polymer imaging, digital pre-press, and pcb marking.


Funded by the Early Advantage Fund
1st Investment: April 2010 | www.lumejet.com
Sector: ICT


Microbial Solutions

Microbial Solutions’ innovative on-site bacterial process can treat metal working fluids in a much more environmentally friendly manner, producing grey water that is safe to dispose of in the sewerage system, and with no methane production in the process - so lower greenhouse gas impact. Water re-use is also possible, and the Company can offer treatment price certainty and stability to manufacturers, on a non-capital investment ‘pay-as-you-treat’ per litre basis.


The technology has been successfully trialed with a leading car manufacturer. Microbial Solutions has now moved to new office and laboratory facilities in Oxfordshire, and following an introduction by Houghton Europe, is also close to completing the first commercial pilot of its patent protected bacterial treatment, known as ‘Microcycle™ Technology’ at the site of a major aerospace manufacturer. RSF made a pathfinder investment in 2004 and the Company raised £1.2m towards the end of 2007 from a syndicate including RSF and Oxford Capital Partners.


Funded by the Rainbow Seed Fund
1st Investment: January 2004 | www.microbial-solutions.com
Sector: Environmental Technologies


Microvisk

Microvisk has a unique approach to the measurement of the viscosity of blood and other fluid, based on CCLRC's considerable expertise in its Central Microfabrication Facility. The patented technology involves the spatial movement of microfabricated thermal bimorohs - bimetallic strips - which is converted into an electric signal using the piezo electric effect. Microvisk's technology can revolutionise the diagnostic market by simplifying the most common coagulation tests (those that are critical to the monitoring of any patient at risk from blood clotting and heart problems) and by providing instant POC and NP testing and analysis.


Funded by the Advantage Growth Fund and the Rainbow Seed Fund
1st Investment: January 2004 | www.microvisk.com
Sector: Medical / Biotechnology


Midland Industrial Glass

Midland Industrial Glass is a precision engineer manufacturing glass components for television stands, shop fitting and leisure equipment as well as for a wide range of other applications. It uses state of the art CNC technology for shape cutting, edging, drilling, bevelling, printing and toughening its products. It specialises in short runs, quick turnrounds and technically difficult products in long runs to set it apart from its competitors.


Funded by the Advantage Growth Fund
1st Investment: June 2005 | www.miglass.com
Sector: Other


MVI Holdings

MVI, established in 1991 developed 'out of the box' real time shop floor data capture and performance management solutions, based on 15 years working with customers including Coca Cola, Pfizer, Gillette and Toyota on their continuous improvement efforts.
The software provided a unique competitive edge resulting in rapid increases in productivity and quality compliance for its users. With investment from the Advantage Growth Fund the company's growth spread to the USA and Canada where the product was identified by analysts as 'best of breed', resulting in a rapidly growing customer base of top transatlantic brand corporations and an ultimate exit by way of trade sale to US based CDC Corporation.
The Advantage Growth Fund successfully exited MVI just 12 months after its initial investment generating an IRR for the fund of some 60%.

Funded by the Advantage Growth Fund
1st Investment: October 2005 | www.mvi.co.uk
Sector: Software


Novacta

Novacta is a drug discovery and development company using pathway engineering and chemistry to optimise the activity of natural products for the treatment of infectious diseases. The company combines proprietary technologies from the world-renowned Actinomycete group of the John Innes Centre, Norwich with the know-how of a highly experienced team drawn from major pharmaceutical companies and the biotechnology industry.

Funded by the Rainbow Seed Fund
1st Investment: January 2005 | www.novactabio.com
Sector: Medical / Biotechnology


Novel Polymer Solutions

Novel Polymer Solutions was formed to exploit a new system of producing radiation curable polymers developed by Qinetiq in their Malvern research centre. This introduces the scope to produce polymers with properties that are novel or otherwise difficult to achieve. The method allows the simple production of mimics of conventional polymers and the creation of new and novel polymers via a radiation curable monomer. Other investors include the Environmental Technologies Fund who invested £3.5m in 2008.


Funded by the Advantage Growth Fund
1st Investment: November 2003 | www.novelpolymers.com
Sector: Environmental Technologies


Occam Systems

Occam Systems Limited is the major supplier in the UK of software for managing student accommodation and events for universities. With a dominant position in the market, Occams' software handles everything from receiving students' applications for accommodation, issuing contracts and managing rooms, through to collecting rent and debt management. The software has grown to manage events, meeting rooms, catering and audio visual services.


Funded by the Advantage Growth Fund
1st Investment: June 2004 | www.occam.co.uk
Sector: Software


Orbital Optics

For several years CCLRC's Space Science and Technology Department at Rutherford Appleton Laboratory has been developing compact, robust, low cost cameras to image Earth from space. The TopSat mission, a collaboration with Surrey Satellites and Technology Ltd and QinetiQ on a BNSC and MoD sponsored project, obtained colour images at a resolution of 2.8m over a 16km field of view. Individual buildings on the ground can be identified at this resolution.


MDA,the Canadian space and defense company, acquired 50% of the conmpany's share capital in 2007 (including the bulk of RSF's holding) with a view to developing it as its European base.  Rainbow made and IRR of 20% in less than 1 year.


Funded by the Rainbow Seed Fund
1st Investment: December 2004 | www.orbitaloptics.co.uk
Sector: ICT


Oxsensis

Oxsensis is pioneering a 'new breed' of optical instrumentation for precision controls in super harsh environments such as highly efficient car and aero engines, and in industrial,electrical,nuclear and space applications.


Funded by the Rainbow Seed Fund
1st Investment: December 2000 | www.oxsensis.com
Sector: Environmental Technologies


P2i

P2i's patented technology employs a special pulsed ionised gas (plasma), which is created within a vacuum chamber, to attach a nanometre-thin polymer layer over the entire surface of a product.  Tests show that P2i's patented nano coating technology can deliver performance benefits for a wide range of materials, including polymers, metals, fabrics, leather, ceramics, glass and paper.  Even complex, 3D objects incorporating several different materials can be treated successfully with the P2i process.  P2i has two consumer brands for its technology: ion mask™, for footwear, outdoor clothing and accessories, and Aridion™, for consumer electronics.  For industrial applications, the technology is covered by the corporate P2i brand.


Funded by the Rainbow Seed Fund
1st Investment: December 2000 | www.p2ilabs.co.uk
Sector: Other


Phasor Solutions

Phasor Solutions, formed in July 2005, has developed an innovative approach to the construction of flat panel phased arrays that can achieve a much lower cost per element. This means that an entire phased array antenna can be built for a cost not a lot more than a mechanically steered parabolic reflector antenna of comparable performance.
Phased Array Antennas are arrays of small antennas. By adjusting the relative phase of the signal received by (or transmitted from) each antenna element it is possible to electronically steer the beam to point precisely in a given direction and to dynamically adjust the beam direction to compensate for movements of the antenna or satellite.

Funded by the Advantage Growth Fund
1st Investment: December 2005 | www.phasorsolutions.com
Sector: ICT


pr2go

pr2go enable businesses of all types and sizes to gain valuable press coverage at an affordable price whenever they need it.  In 24 hours pr2go will guarantee to write professional press releases and then distribute them to all the relevant media required by the customer.  They supply a cost effective online virtual marketing agency.  They will deliver this discipline at a fraction of the cost of traditional PR agencies. pr2go intend to replicate the proposition concentrating on other key marketing services such as creative design and new media.


Funded by the Exceed - Midlands Advantage Fund
1st Investment: June 2010 | www.pr2go.com
Sector: Services


Procarta Biosystems

Procarta Biosystems is a spin-out from one of Europe's leading microbiology departments at the John Innes Centre. The company, formed in early 2008, is investigating a novel approach to counter antibiotic resistance and defeat infectious diseases using a DNA decoy technique, which aims to restore antibiotic efficacy against resistant superdrugs, such as methicillin-resistent Staphylococcus aureus (MRSA) and vancomycin-resistant Entercoccus (VRE).

Accessing the skills in the John Innes Centre, Procarta is also able to offer a contract research service creating and improving Streptomyces strains for heterologous production.

Funded by the Rainbow Seed Fund
1st Investment: January 2008 | www.procartabio.com
Sector: Medical / Biotechnology


ProKyma

ProKyma is based on Dstl's proprietary ultrasound technology for manipulating particles.

Sensitive detection methods are limited by the purity of the starting material. Techniques are available to purify and concentrate biological specimens but these methods are often labour intensive or only partly effective. Major improvements in analysing biological samples such as bacteria, cells and DNA require improved sample preparation. ProKyma's Sonic Separation technology provides a means for concentrating and purifying cells or micro-organisms. Sonic Separation can also be used to isolate or analyse cell aggregates, for example in blood grouping and serology.

Funded by the Rainbow Seed Fund
1st Investment: January 2006 | www.prokyma.com
Sector: Medical / Biotechnology


Prolojik

Prolojik is a leading lighting management provider. They design, manufacture and deliver lighting controls solutions to a number of leading financial, pharmaceutical, educational, government and commercial property development organisations.

Funded by the Advantage Growth Fund
1st Investment: December 2000 | www.prolojik.com
Sector: Other


Quantum Risk Management

Quantum Risk Management provides tailored, cost effective solutions to risk management problems. They aim to help their clients achieve sustained improvement by providing services ranging from risk assessments, through corporate auditing, to health and safety management systems.


Funded by the Advantage Growth Fund
1st Investment: February 2003 | www.q-rm.co.uk
Sector: Services


SALT

Subsea Asset Location Technologies Ltd (SALT) is a spin-out company from the Defence Science and Technology Laboratory (Dstl), a research agency of the UK Ministry of Defence (MOD).  The company was formed to exploit a new passive sonar reflector technology for the commercial marketplace.  The product SonarBell™ works by focusing the sound energy like a lens to amplify sound levels and reflect them to the sender.  This ability is delivered solely through the mechanical properties of the chosen materials and its construction.


Funded by the Rainbow Seed Fund
1st Investment: January 2008 | www.cesalt.co.uk
Sector: Other


ScriptSwitch

ScriptSwitch is the market leading provider of an innovative prescribing software product to NHS Primary Care Trusts, which is then employed by GPs in their surgeries. The software is a sophisticated medicines management tool that delivers consistency and conformity in prescribing whilst quantifying and reporting on cost savings. The product has enabled PCT's to save millions of pounds from their drug budgets. The Advantage Growth Fund backed Scriptswitch as a start-up business and achieved a partial exit in 2007, following a significant investment of development capital by Isis Equity Partners, generating an IRR to date for the fund of 67%.


Funded by the Advantage Growth Fund
1st Investment: July 2003 | www.scriptswitch.com
Sector: Software


Silver Lining Solutions

Silver Lining Solutions, formed in 1999, is an online skills assessment specialist. It develops software for training needs analysis, compliance testing, and knowledge assessment. Sales are to both public and private sector and a significant sale to the O2 call centre has opened the call centre market to the Company. Its product 'Discover' automates the processes for testing operatives' skills and embedding the results into switching software. The result for the call centre is that callers are put through to the operative best able to deal with their query.


Funded by the Advantage Growth Fund
1st Investment: December 2004 | www.silverlining.uk.net
Sector: Software


Simworx

Simworx are market leaders in 3D/4D effects theatres, motion theatres, simulation attractions and the provision of 2D/3D film content. The Company's leading edge products are sold worldwide and can be found in a significant number of high profile amusement parks and museums.

Funded by the Advantage Growth Fund
1st Investment: January 2008 | www.simworx.co.uk
Sector: Other


Speed Plastics

Speed Plastics manufactures a wide range of specialist products from flexible plastics such as PVC, polyurethane film, polyester and polyurethane coated textiles, used in the medical, surgical and furniture industries. We have also developed our own products for use in the leisure industry, such as inflatable buoyancy bags for use in water sports, and sensory learning aids for children. For many years the company has been at the forefront of technology, manufacturing and developing defence and survival products on behalf of the Ministry of Defence and civilian medical evacuation authorities.

Funded by the HSBC Enterprise Fund
1st Investment: November 2000 | www.speedplastics.co.uk
Sector: Other


Streamline Computing

Streamline Computing installs and maintains super-computer clusters,to form High Performance Computing (HPC)systems. Over the past seven years,Streamline has been responsible for the implementation and support of hundreds of cluster installations,including several Top500 systems. The company's investors include the Advantage Growth Fund,Oxford Capital Partners and Forward Group.

Funded by the Advantage Growth Fund
1st Investment: May 2005 | www.streamline-computing.com
Sector: ICT


T@lecom

T@lecom is a provider of a range of end to end wireless applications for handheld devices enabling an increasingly mobile workforce to communicate seamlessly with their office. The Company was a start-up in 2003 and has since developed a particularly strong position in the providing solutions to the NHS.

Funded by the Advantage Growth Fund
1st Investment: June 2003 | www.talecom.net
Sector: ICT


WalkinWifi Limited

WalkinWiFi™ provides totally free of charge Wi-Fi internet access to members of the public, across a national network, in return for their agreement to be marketed to, via e-mail and text message, by the location at which they first register for use of the system. WalkinWiFi™ then provides a web based marketing message delivery suite for the location to be able to simply and cost effectively send out offers and updates to encourage customers to return to site.


Funded by the Early Advantage Fund
1st Investment: July 2010 | www.walkinwifi.com
Sector: ICT


Warwick Effect Polymers

Warwick Effect Polymers has developed a new technology, transition metal mediated Living Radical Polymerisation, which allows the production of complex polymers under greater control than conventional polymerisation techniques. The company is looking to exploit its platform technology to become a provider of polymer technology to the pharmaceutical and healthcare industries.


Funded by the Advantage Growth Fund
1st Investment: December 2003 | www.warwickeffectpolymers.co.uk
Sector: Environmental Technologies